Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)
CUSIP: 83422E204
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 92,783,558
- Total 13F shares
- 37,594,933
- Share change
- +2,594,716
- Total reported value
- $213,228,886
- Put/Call ratio
- 537%
- Price per share
- $5.67
- Number of holders
- 78
- Value change
- +$13,669,240
- Number of buys
- 53
- Number of sells
- 21
Quarterly Holders Quick Answers
What is CUSIP 83422E204?
CUSIP 83422E204 identifies SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 83422E204:
Top shareholders of SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
7.4%
|
6,906,646
|
$91,996,524 | — | 31 Mar 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.7%
|
4,330,446
|
$57,681,541 | — | 31 Mar 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
4.3%
|
4,034,582
|
$53,740,632 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.7%
|
2,538,897
|
$33,818,108 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
2.7%
|
2,500,000
|
$33,300,000 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.4%
|
2,260,398
|
$30,108,501 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.9%
|
1,808,440
|
$23,934,714 | — | 31 Mar 2024 | |
| Adam Koppel |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
4,044,232
mixed-class rows
|
$22,311,238 | — | 11 Jan 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
1,325,065
|
$17,649,866 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
1,244,575
|
$16,577,739 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.1%
|
1,035,000
|
$13,786,200 | — | 31 Mar 2024 | |
| Finepoint Capital LP |
13F
|
Company |
1%
|
961,251
|
$12,803,863 | — | 31 Mar 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
1%
|
928,169
|
$12,363,211 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.79%
|
733,081
|
$9,764,639 | — | 31 Mar 2024 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.67%
|
620,000
|
$8,258,400 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.62%
|
576,267
|
$7,675,876 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.51%
|
472,107
|
$6,288,465 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.45%
|
414,615
|
$5,522,672 | — | 31 Mar 2024 | |
| BCLS II Equity Opportunities GP, LLC |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
904,160
|
$5,000,005 | — | 11 Jan 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.33%
|
307,066
|
$4,090,119 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
237,673
|
$3,167,018 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.23%
|
217,392
|
$2,895,661 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.22%
|
203,748
|
$2,713,923 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.22%
|
203,204
|
$2,706,677 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.14%
|
130,648
|
$1,740,231 | — | 31 Mar 2024 | |
| Atom Investors LP |
13F
|
Company |
0.11%
|
101,509
|
$1,352,100 | — | 31 Mar 2024 | |
| Joel Solomon Zev Schneider |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
236,270
|
$1,306,573 | — | 14 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
87,388
|
$1,164,008 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
86,004
|
$1,145,573 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
73,294
|
$976,276 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.08%
|
70,277
|
$936,090 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.07%
|
68,771
|
$916,000 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.07%
|
65,540
|
$872,993 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
51,057
|
$680,079 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.05%
|
48,922
|
$651,641 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
47,712
|
$635,524 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
41,908
|
$558,215 | — | 31 Mar 2024 | |
| Marathon Trading Investment Management LLC |
13F
|
Company |
0.04%
|
37,300
|
$496,836 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
34,425
|
$458,541 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
30,361
|
$404,409 | — | 31 Mar 2024 | |
| Jennifer Marlowe |
3/4/5
|
CSO |
—
mixed-class rows
|
141,998
mixed-class rows
|
$398,249 | — | 13 Feb 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.03%
|
24,704
|
$329,057 | — | 31 Mar 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.03%
|
24,085
|
$321,000 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.03%
|
23,525
|
$313,353 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
22,185
|
$295,507 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.02%
|
14,500
|
$193,140 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
14,249
|
$189,797 | — | 31 Mar 2024 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.01%
|
13,259
|
$176,610 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
10,276
|
$136,876 | — | 31 Mar 2024 | |
| Carl Ashley Morris |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
23,460
mixed-class rows
|
$128,883 | — | 27 Jan 2023 |
Institutional Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q2 2024
As of 30 Jun 2024,
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,594,933 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Bain Capital Life Sciences Investors, LLC, Vestal Point Capital, LP, Artal Group S.A., ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MILLENNIUM MANAGEMENT LLC, BlackRock Inc., and ADAR1 Capital Management, LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
52
Q2 2024 holders
78
Holder diff
26
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.